Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Reformulated Oral Angiogenesis Inhibitor is Effective and Nontoxic

By Biotechdaily staff writers
Posted on 16 Jul 2008
Cancer researchers have modified a powerful angiogenesis-inhibiting drug to be nontoxic and suitable for oral administration.

The original drug, the fumagillin analog TNP-470, was discovered nearly 20 years ago. More...
It is among the most potent and broad-spectrum angiogenesis inhibitors available to clinical researchers. However, a major clinical limitation is its poor oral availability and short half-life, necessitating frequent, continuous parenteral administration.

Several years ago TNP-470 was reformulated by attaching a large polymer to prevent it from crossing the blood-brain barrier. In this formulation, Caplostatin has no neurotoxicity and is in development for clinical trials. However, it too must be given intravenously.

The current article in the June 29, 2008, online edition of the journal Nature Biotechnology describes a new version of TNP-470 that has been modified by being conjugated to monomethoxy-polyethylene glycol–polylactic acid to form nanopolymeric micelles. This conjugate, called Lodamin (based on the Hebrew word meaning "no blood”), can be absorbed by the intestine and selectively accumulates in tumors. Lodamin significantly inhibits tumor growth, without causing neurologic impairment in tumor-bearing mice. Using the oral route of administration, it first reaches the liver, making it especially efficient in preventing the development of liver metastasis in mice.

"This was one of the most surprising things I saw,” said first author Dr. Ofra Benny, a researcher at Children's Hospital (Boston, MA, USA). "When I looked at the livers of the mice, the treated group was almost clean. In the control group, you could not recognize the livers--they were a mass of tumors. I had never expected such a strong effect on these aggressive tumor models.”


Related Links:
Children's Hospital

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.